The ryanodine receptor channel as a molecular motif in atrial fibrillation: Pathophysiological and therapeutic implications

Cardiovascular Research

Volumn 89, Issue 4, 2011, Pages 734-743

  Dobrev, Dobromir ^a   Voigt, Niels ^a   Wehrens, Xander H T ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Calcium handling; Remodelling; Ryanodine

Indexed keywords

RYANODINE RECEPTOR;

CALCIUM HOMEOSTASIS; HEART ATRIUM FIBRILLATION; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SARCOPLASMIC RETICULUM; UPREGULATION;

ANIMALS; ATRIAL FIBRILLATION; CALCIUM; CALCIUM SIGNALING; HEART ATRIA; HUMANS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SODIUM-CALCIUM EXCHANGER;

EID: 79951894322     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq324     Document Type: Review

References (103)

1. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004; 110:1042-1046. (Pubitemid 39319000)
2. Dobrev D, Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet 2010;375:1212-1223.
3. Schotten U, Ausma J, Stellbrink C, Sabatschus I, Vogel M, Frechen D et al. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 2001;103:691-698. (Pubitemid 32144198)
4. 2+ release in right atrial myocytes from experimental persistent atrial fibrillation. Circ Res 2009;105:876-885.
5. Sun H, Gaspo R, Leblanc N, Nattel S. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia. Circulation 1998;98:719-727. (Pubitemid 28387499)
6. Wakili R, Yeh HS, Qi XY, Greiser M, Chartier D, Nishida K et al. Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ Arrhythm Electrophysiol 2010;3:530-541.
7. Dobrev D, Nattel S. Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics. J Cardiovasc Pharmacol 2008;52:293-299.
8. 2+ in cardiac myocytes. J Gen Physiol 2008;132:721-730.
9. 2+ signaling in the heart: the role of ryanodine receptor sensitivity. J Gen Physiol 2010;136:135-142.
10. 2+ sparks: an investigative mathematical model of calcium-induced calcium release. Biophys J 2002;83:59-78.
11. Stern MD, Song LS, Cheng H, Sham JS, Yang HT, Boheler KR et al. Local control models of cardiac excitation-contraction coupling: a possible role for allosteric interactions between ryanodine receptors. J Gen Physiol 1999;113:469-489. (Pubitemid 29219815)
12. Nattel S. Basic electrophysiology of the pulmonary veins and their role in atrial fibrillation: precipitators, perpetuators, and perplexers. J Cardiovasc Electrophysiol 2003; 14:1372-1375. (Pubitemid 38037478)
13. Michael G, Xiao L, Qi XY, Dobrev D, Nattel S. Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis. Cardiovasc Res 2009;81:491-499.
14. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 2008;1:62-73.
15. 2+ signaling in atrial fibrillation as an antiarrhythmic drug target. Naunyn Schmiedebergs Arch Pharmacol 2010;381:195-206.
16. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666. (Pubitemid 28402090)
17. Burashnikov A, Antzelevitch C. Late-phase 3 EAD: a unique mechanism contributing to initiation of atrial fibrillation. Pacing Clin Electrophysiol 2006;29:290-295. (Pubitemid 43881405)
18. Santiago DJ, Curran JW, Bers DM, Lederer WJ, Stern MD, Rios E et al. Ca sparks do not explain all ryanodine receptor-mediated SR Ca leak in mouse ventricular myocytes. Biophys J 98:2111-2120.
19. 2+ release causes myocyte depolarization: underlying mechanism and threshold for triggered action potentials. Circ Res 2000;87:774-780.
20. Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium - calcium exchange, inward rectifier potassium current, and residual β-adrenergic responsiveness. Circ Res 2001;88: 1159-1167. (Pubitemid 34132516)
21. Santonastasi M, Wehrens XH. Ryanodine receptors as pharmacological targets for heart disease. Acta Pharmacol Sin 2007;28:937-944. (Pubitemid 47020482)
22. Lehnart SE, Terrenoire C, Reiken S, Wehrens XH, Song LS, Tillman EJ et al. Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias. Proc Natl Acad Sci USA 2006;103:7906-7910.
23. Benardeau A, Hatem SN, Rucker-Martin C, Tessier S, Dinanian S, Samuel JL et al. Primary culture of human atrial myocytes is associated with the appearance of structural and functional characteristics of immature myocardium. J Mol Cell Cardiol 1997; 29:1307-1320. (Pubitemid 27259645)
24. 2+ signaling. J Mol Cell Cardiol 2009;46:448-451.
25. 2+ current. Circ Res 2001;88:195-201.
26. Koss KL, Grupp IL, Kranias EG. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility. Bas Res Cardiol 1997;92(Suppl. 1): 17-24. (Pubitemid 27254277)
27. Walden AP, Dibb KM, Trafford AW. Differences in intracellular calcium homeostasis between atrial and ventricular myocytes. J Mol Cell Cardiol 2009;46:463-473.
28. Forbes MS, Van Niel EE, Purdy-Ramos SI. The atrial myocardial cells of mouse heart: a structural and stereological study. J Struct Biol 1990;103:266-279.
29. Wehrens XH, Lehnart SE, Marks AR. Intracellular calcium release and cardiac disease. Annu Rev Physiol 2005;67:69-98. (Pubitemid 40404486)
30. Chelu MG, Wehrens XH. Sarcoplasmic reticulum calcium leak and cardiac arrhythmias. Biochem Soc Trans 2007;35:952-956. (Pubitemid 350206403)
31. Zhang L, Kelley J, Schmeisser G, Kobayashi YM, Jones LR. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor: proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 1997;272: 23389-23397. (Pubitemid 27392481)
32. 2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proc Natl Acad Sci USA 2009;106:7636-7641.
33. Yuan Q, Fan GC, Dong M, Altschafl B, Diwan A, Ren X et al. Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity. Circulation 2007;115:300-309. (Pubitemid 46148506)
34. Marx SO, Reiken S, Hisamatsu Y, Gaburjakova M, Gaburjakova J, Yang YM et al. Phosphorylation-dependent regulation of ryanodine receptors: a novel role for leucine/isoleucine zippers. J Cell Biol 2001;153:699-708. (Pubitemid 34286103)
35. Vest JA, Wehrens XH, Reiken SR, Lehnart SE, Dobrev D, Chandra P et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005;111: 2025-2032. (Pubitemid 40577896)
36. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000;101:365-376.
37. 2+/calmodulin- dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ Res 2004;94:e61-e70.
38. Hove-Madsen L, Llach A, Bayes-Genis A, Roura S, Rodriguez Font E, Aris A et al. Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 2004;110: 1358-1363. (Pubitemid 39238013)
39. Dobrev D. Electrical remodeling in atrial fibrillation. Herz 2006;31:108-112. (Pubitemid 43899995)
40. 2+ events in atrial myocytes of patients with atrial fibrillation. Cardiology 2008;111: 102-110.
41. 2+ levels in right atrial myocardium of patients with atrial fibrillation. Circ Res 2010;106:1134-1144.
42. Voigt N, Traffords AW, Ravens U, Dobrev D. Increased diastolic sarcoplasmic reticulum calcium leak may contribute to arrhythmogenesis in patients with atrial fibrillation. Cardiovasc Res 2010;87:S53 (abstract).
43. 2+ signaling in patients with chronic atrial fibrillation. Circulation 2009; 120:S667-S668 (abstract).
44. Schotten U, Greiser M, Benke D, Buerkel K, Ehrenteidt B, Stellbrink C et al. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. Cardiovasc Res 2002;53:192-201. (Pubitemid 34020780)
45. 2+ handling in human chronic atrial fibrillation. Circulation 2006;114:670-680.
46. Brundel BJ, van Gelder IC, Henning RH, Tuinenburg AE, Deelman LE, Tieleman RG et al. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc Res 1999;42:443-454. (Pubitemid 29243170)
47. 2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol 1999;33:1231-1237.
48. 2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation. J Am Coll Cardiol 1999;34:255-263.
49. 2+ signaling in a chronic dog model of atrial fibrillation. Cardiology 2007;107:269-276.
50. Greiser M, Neuberger HR, Harks E, El-Armouche A, Boknik P, de Haan S et al. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. J Mol Cell Cardiol 2009;46:385-394.
51. 2+ leak promotes atrial fibrillation in mice. J Clin Invest 2009;119:1940-1951.
52. Yeh YH, Wakili R, Qi XY, Chartier D, Boknik P, Kaab S et al. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol 2008;1:93-102.
53. Sood S, Chelu MG, van Oort RJ, Skapura D, Santonastasi M, Dobrev D et al. Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. Heart Rhythm 2008;5:1047-1054.
54. Antos CL, Frey N, Marx SO, Reiken S, Gaburjakova M, Richardson JA et al. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A. Circ Res 2001;89:997-1004. (Pubitemid 34640866)
55. Xiao B, Jiang MT, Zhao M, Yang D, Sutherland C, Lai FA et al. Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure. Circ Res 2005;96:847-855. (Pubitemid 40604968)
56. 2+/calmodulin-dependent protein kinases II in human atrial myocytes. Circ Res 1999;85:810-819.
57. 2+ leak, and atrial fibrillation. Trends Cardiovasc Med 2010;20:30-34.
58. Greiser M, Halaszovich CR, Frechen D, Boknik P, Ravens U, Dobrev D et al. Pharmacological evidence for altered src kinase regulation of I(Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 2007;375:383-392. (Pubitemid 47087500)
59. Herzig S, Neumann J. Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol Rev 2000;80:173-210. (Pubitemid 30060564)
60. El-Armouche A, Wittkopper K, Degenhardt F, Weinberger F, Didie M, Melnychenko I et al. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. Cardiovasc Res 2008;80:396-406.
61. Wittkopper K, Fabritz L, Neef S, Ort KR, Grefe C, Unsold B et al. Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging. J Clin Invest 2010;120: 617-626.
62. Witcher DR, Kovacs RJ, Schulman H, Cefali DC, Jones LR. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J Biol Chem 1991;266:11144-11152. (Pubitemid 21906924)
63. Venetucci LA, Trafford AW, Eisner DA. Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: threshold sarcoplasmic reticulum calcium content is required. Circ Res 2007;100:105-111. (Pubitemid 46066778)
64. Xiao B, Tian X, Xie W, Jones PP, Cai S, Wang X et al. Functional consequence of protein kinase A-dependent phosphorylation of the cardiac ryanodine receptor: sensitization of store overload-induced Ca2+ release. J Biol Chem 2007;282: 30256-30264. (Pubitemid 350035276)
65. Kubalova Z, Terentyev D, Viatchenko-Karpinski S, Nishijima Y, Gyorke I, Terentyeva R et al. Abnormal intrastore calcium signaling in chronic heart failure. Proc Natl Acad Sci USA 2005;102:14104-14109. (Pubitemid 41377710)
66. 2+ release (SOICR). Proc Natl Acad Sci USA 2004;101: 13062-13067.
67. Bhupathy P, Babu GJ, Ito M, Periasamy M. Threonine-5 at the N-terminus can modulate sarcolipin function in cardiac myocytes. J Mol Cell Cardiol 2009;47:723-729.
68. Uemura N, Ohkusa T, Hamano K, Nakagome M, Hori H, Shimizu M et al. Downregulation of sarcolipin mRNA expression in chronic atrial fibrillation. Eur J Clin Invest 2004;34:723-730. (Pubitemid 39524296)
69. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kuhlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 1999;44:121-131. (Pubitemid 29431690)
70. 2+ currents and human atrial fibrillation. Circ Res 1999;85:428-436.
71. Christ T, Boknik P, Wohrl S, Wettwer E, Graf EM, Bosch RF et al. L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 2004;110:2651-2657. (Pubitemid 39453015)
72. Schulze DH, Muqhal M, Lederer WJ, Ruknudin AM. Sodium/calcium exchanger (NCX1) macromolecular complex. J Biol Chem 2003;278:28849-28855. (Pubitemid 36935795)
73. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G et al. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 2005;112: 471-481. (Pubitemid 41060786)
74. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995;92: 1954-1968.
75. 2+- calmodulin-dependent protein kinase II. J Mol Cell Cardiol 2010;49:25-32.
76. 2+ in the heart. Circ Res 2008;103:509-518.
77. Dobrev D, Friedrich A, Voigt N, Jost N, Wettwer E, Christ T et al. The G proteingated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation. Circulation 2005;112:3697-3706. (Pubitemid 43739509)
78. + current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials. Circulation 2001;104:2551-2557.
79. Dobrev D, Wettwer E, Kortner A, Knaut M, Schuler S, Ravens U. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res 2002;54:397-404. (Pubitemid 34327918)
80. Voigt N, Trausch A, Knaut M, Matschke K, Varro A, Van Wagoner DR et al. Left-to-right atrial inward-rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3: 472-480.
81. K,ACh channels in patients with chronic atrial fibrillation. Cardiovasc Res 2007;74:426-437.
82. Voigt N, Maguy A, Yeh YH, Qi X, Ravens U, Dobrev D et al. Changes in IK,ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovasc Res 2008;77:35-43. (Pubitemid 351195163)
83. Maruyama M, Joung B, Tang L, Shinohara T, On YK, Han S et al. Diastolic intracellular calcium-membrane voltage coupling gain and postshock arrhythmias: role of Purkinje fibers and triggered activity. Circ Res 2010;106:399-408.
84. Venetucci LA, Trafford AW, O'Neill SC, Eisner DA. The sarcoplasmic reticulum and arrhythmogenic calcium release. Cardiovasc Res 2008;77:285-292. (Pubitemid 351197634)
85. 2+ leak and enhanced NCX increase occurrence delayed afterdepolarisations in atrial myocytes from patients with chronic atrial fibrillation. Circulation, in press (abstract).
86. Xie LH, Chen F, Karagueuzian HS, Weiss JN. Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling. Circ Res 2009;104:79-86.
87. Patterson E, Jackman WM, Beckman KJ, Lazzara R, Lockwood D, Scherlag BJ et al. Spontaneous pulmonary vein firing in man: relationship to tachycardia-pause early afterdepolarizations and triggered arrhythmia in canine pulmonary veins in vitro. J Cardiovasc Electrophysiol 2007;18:1067-1075. (Pubitemid 47416568)
88. Kumagai K, Nakashima H, Gondo N, Saku K. Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model. J Cardiovasc Electrophysiol 2003;14:880-884. (Pubitemid 36994108)
89. Wehrens XH, Marks AR. Novel therapeutic approaches for heart failure by normalizing calcium cycling. Nat Rev Drug Discov 2004;3:565-573. (Pubitemid 39022986)
90. Wehrens XH, Lehnart SE, Reiken SR, Deng SX, Vest JA, Cervantes D et al. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 2004;304:292-296. (Pubitemid 38452182)
91. Chen YJ, Chen YC, Wongcharoen W, Lin CI, Chen SA. Effect of K201, a novel antiarrhythmic drug on calcium handling and arrhythmogenic activity of pulmonary vein cardiomyocytes. Br J Pharmacol 2008;153:915-925. (Pubitemid 351328929)
92. Nakaya H, Furusawa Y, Ogura T, Tamagawa M, Uemura H. Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts. Br J Pharmacol 2000;131:1363-1372.
93. 2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J Clin Invest 2008;118:2230-2245.
94. Voigt N, Rozmaritsa N, Trausch A, Zimniak T, Christ T, Wettwer E et al. Inhibition of I(K,ACh) current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 2010;381:251-259.
95. Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 2009;15:380-383.
96. 2+ spark mass. J Mol Cell Cardiol 2010; 48:293-301.
97. Lehnart SE, Lederer WJ. An antidote for calcium leak: targeting molecular arrhythmia mechanisms. J Mol Cell Cardiol 2010;48:279-282.
98. Qi XY, Yeh YH, Xiao L, Burstein B, Maguy A, Chartier D et al. Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ Res 2008; 103:845-854.
99. Backs J, Stein P, Backs T, Duncan FE, Grueter CE, McAnally J et al. The gamma isoform of CaM kinase II controls mouse egg activation by regulating cell cycle resumption. Proc Natl Acad Sci USA 107:81-86.
100. Kushnir A, Shan J, Betzenhauser MJ, Reiken S, Marks AR. Role of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure. Proc Natl Acad Sci USA 2010;107:10274-10279.
101. Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008;133:462-474. (Pubitemid 351608692)
102. Van Wagoner DR. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol 2008;52: 306-313.
103. Goette A, Bukowska A, Dobrev D, Pfeiffenberger J, Morawietz H, Strugala D et al. Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Eur Heart J 2009;30:1411-1420.